• Print
  • |
  • |
  • PDF


Miller Nash Graham & Dunn works with companies at all stages of development in the biotechnology sector. Our attorneys have assisted biotechnology companies in entity formation, grant funding, early stage investment, public securities offerings, securities law compliance, research and development contracts and joint ventures, inbound and outbound technology licensing, mergers and acquisitions, and other corporate transactions.

Our intellectual property team includes counsel with both business and science backgrounds relevant to growing biotechnology companies. We handle extensive patent and intellectual property portfolios for our biotechnology clients.

Like other businesses, biotechnology companies encounter issues in areas such as employment, benefits, tax, and environmental compliance. Miller Nash Graham & Dunn attorneys regularly assist and advise clients on all of these matters.

Representative Experience

Assisted a biotechnology client with a merger into a larger affiliated company. Our work included performing due diligence to identify potential risks, determining the scope of the businesses' patent rights in valuable technology, and preparing merger documents and corporate filings related to the transaction.
Advised client’s board of directors in developing and proposing appropriate merger terms. Conducted due diligence process. Prepared and negotiated merger agreement and related transaction documents. Assisted with obtaining required board and shareholder approvals.
Assisted biotechnology company in approximately $12 million preferred stock financing from a venture capital fund.